LZYY(SH:603368)2023-04-19 16:00Financial Performance - The company achieved operating revenue of CNY 5.33 billion in Q1 2023, representing a year-on-year increase of 10.83%[6]. - Net profit attributable to shareholders reached CNY 261.07 million, up 18.16% compared to the same period last year[6]. - The wholesale segment generated a profit of CNY 181.69 million, while the retail segment's profit was CNY 32.72 million, reflecting a 4.99% increase despite a revenue decline[6]. - The industrial segment saw a significant revenue increase of 81.29%, contributing a net profit of CNY 45.61 million[8]. - Total operating revenue for Q1 2023 reached ¥5,334,761,606.27, an increase of 10.9% compared to ¥4,813,503,290.88 in Q1 2022[23]. - Net profit for Q1 2023 was ¥270,305,830.30, representing a 17.0% increase from ¥230,942,512.59 in Q1 2022[25]. - The company reported a total profit of ¥309,028,912.60 for Q1 2023, up from ¥270,918,902.01 in Q1 2022[24]. Cash Flow and Liquidity - The company reported a net cash flow from operating activities of CNY -542.43 million, indicating a significant cash outflow during the quarter[3]. - Cash flow from operating activities in Q1 2023 was negative at -¥542,426,332.72, an improvement from -¥717,602,736.95 in Q1 2022[29]. - The net cash flow from investment activities was -54,816,225.94 CNY, compared to -150,331,592.05 CNY in the previous period, indicating an improvement[30]. - Cash inflow from financing activities totaled 1,248,784,863.59 CNY, while cash outflow was 1,419,294,241.11 CNY, resulting in a net cash flow of -170,509,377.52 CNY[30]. - The ending balance of cash and cash equivalents was 1,885,881,118.63 CNY, down from 2,619,072,714.35 CNY in the previous period[30]. - The company reported a net increase in cash and cash equivalents of -767,751,936.18 CNY, compared to -642,688,559.05 CNY previously[30]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 18.91 billion, a 1.60% increase from the end of the previous year[4]. - As of March 31, 2023, the total assets of Guangxi Liuyuan Group Co., Ltd. amounted to CNY 18,905,519,858.13, an increase from CNY 18,606,991,646.91 at the end of 2022[18]. - The company's current assets totaled CNY 16,421,324,203.65, slightly up from CNY 16,125,160,344.54 at the end of 2022, with cash and cash equivalents decreasing to CNY 2,615,024,264.85 from CNY 3,854,652,775.37[17]. - The total liabilities of the company were CNY 12,282,642,131.28, compared to CNY 12,241,643,740.63 at the end of 2022, showing a slight increase[19]. - The company's equity attributable to shareholders rose to CNY 6,217,260,643.27 from CNY 5,968,964,510.96, reflecting an increase of about 4.2%[20]. Operational Efficiency - The company has completed the filing of over 400 varieties for its traditional Chinese medicine granule production project, laying the groundwork for future revenue growth[6]. - The retail segment's revenue decreased by 5.23%, accounting for 12.23% of total revenue[8]. - The company is actively expanding its market presence outside the province while enhancing product promotion efforts in existing markets[6]. - Research and development expenses increased to ¥7,756,228.00 in Q1 2023, up from ¥4,107,655.99 in Q1 2022, reflecting a focus on innovation[24]. - Sales expenses for Q1 2023 were ¥115,518,281.07, slightly higher than ¥111,884,844.04 in Q1 2022[24]. - Management expenses rose to ¥112,824,884.93 in Q1 2023, compared to ¥97,285,981.13 in Q1 2022[24]. Shareholder Returns - Basic and diluted earnings per share for Q1 2023 were both ¥0.72, compared to ¥0.61 in Q1 2022[25]. - Cash paid for dividends and interest was 192,019,343.88 CNY, significantly higher than 46,523,245.89 CNY previously[30].